| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9de20d302dd257d25edea33c2547d47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b62c9a97370bacaa2ba6be4d37a2cc2e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
| filingDate |
2010-04-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f39b64947ce2772f7e383a1e31b4c0e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f950388c1f74f68aba6ffc669bf75a |
| publicationDate |
2010-10-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010267657-A1 |
| titleOfInvention |
Antimetabolite agent combinations in the treatment of cancer |
| abstract |
A method treating cancer in a subject comprises administering to the subject a therapeutically effective amount of an antimetabolite agent that induces formation of AP sites in cancer cells of the subjects and an amount AP endonuclease inhibitor effective to potentiate the cytotoxicity of the antimetabolite agent to the cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3399967-A4 |
| priorityDate |
2009-04-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |